Blood-derived topical therapy for ocular surface diseases

NG Soni, BH Jeng - British Journal of Ophthalmology, 2016 - bjo.bmj.com
Human serum-derived and plasma-derived therapies have become increasingly popular in
the treatment of ocular surface disorders, with mounting clinical and scientific evidence …

Blood-based treatments for severe dry eye disease: the need of a consensus

F Bernabei, M Roda, M Buzzi, M Pellegrini… - Journal of Clinical …, 2019 - mdpi.com
The use of blood-based eye drops as therapy for various diseases of the ocular surface has
become increasingly popular in ophthalmic practice during recent years. The rationale for …

Autologous serum and alternative blood products for the treatment of ocular surface disorders

G Geerling, JD Unterlauft, K Kasper, S Schrader… - Der …, 2008 - Springer
Eye drops made from autologous serum have been increasingly used in the past decade to
treat ocular surface disorders such as persistent epithelial defects and dry eye. Due to …

Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American Academy of Ophthalmology

RM Shtein, JF Shen, AN Kuo, KM Hammersmith, JY Li… - Ophthalmology, 2020 - Elsevier
Purpose To describe the safety and effectiveness of using autologous serum-based eye
drops for the treatment of severe dry eye and persistent corneal epithelial defect. Methods …

Blood derived eye drops for the treatment of cornea and ocular surface diseases

G Giannaccare, P Versura, M Buzzi, L Primavera… - … and Apheresis Science, 2017 - Elsevier
The use of blood derived eye drops for the treatment of ocular surface disorders has become
increasingly popular in recent years. The mechanism of action is the stimulation of cellular …

Autologous serum eye drops for ocular surface disorders

G Geerling, S Maclennan, D Hartwig - British Journal of …, 2004 - bjo.bmj.com
Tears have antimicrobial, nourishing, mechanical, and optical properties. They contain
components such as growth factors, fibronectin, and vitamins to support proliferation …

[HTML][HTML] Clinical evaluation of allogeneic eye drops from cord blood platelet lysate

D Samarkanova, S Martin, L Bisbe, J Puig… - Blood …, 2021 - ncbi.nlm.nih.gov
Background Current treatments for several corneal lesions show limited efficacy. Here we
report the clinical evaluation of the efficacy of a novel eye drop preparation produced in a …

Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies

E Anitua, F Muruzabal, A Tayebba… - Acta …, 2015 - Wiley Online Library
The use of blood derivatives represents an alternative therapeutic approach that is gaining
interest in regenerative medicine due to its potential to stimulate and accelerate tissue …

Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel

BH Koffler - The ocular surface, 2006 - Elsevier
Application of autologous serum to treat a multitude of ocular surface diseases and
conditions is a relatively new technique that has gained popularity over the past 10 years …

Quality standards, safety and efficacy of blood-derived serum eye drops: a review

PF van der Meer, J Seghatchian, DC Marks - Transfusion and Apheresis …, 2016 - Elsevier
Serum eye drops (SEDs) are being used increasingly to treat dry eye syndrome and
persistent corneal epithelial defects, and are usually prescribed when conventional …